Stockscreener 앱 받기
1.88
5.05%
-0.10
시간 외 거래:
1.87
-0.010
-0.53%
전일 마감가:
$1.98
열려 있는:
$1.93
하루 거래량:
169.50K
Relative Volume:
1.56
시가총액:
$19.45M
수익:
$1.65M
순이익/손실:
$-5.66M
주가수익비율:
-1.5932
EPS:
-1.18
순현금흐름:
-
1주 성능:
-24.19%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.6991
$2.005
1주일 범위
$1.6991
$2.70
52주 변동 폭
$1.6991
$14.09
20 20 Biolabs Inc Stock (AIDX) Company Profile
Compare AIDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AIDX
20 20 Biolabs Inc
|
1.88 | 20.49M | 1.65M | -5.66M | 0 | -1.18 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
20 20 Biolabs Inc 주식(AIDX)의 최신 뉴스
Debt to equity ratio of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
AIDX: 20/20 Biolabs Inc.Options Chain - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Long Term Debt (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Return On Assets (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Expenses (TTM) - Zacks Investment Research
Cash per share of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Michael A. Ross Net Worth (2026) - GuruFocus
Michael Saul Lebowitz Net Worth (2026) - GuruFocus
Jonathan M Cohen Net Worth (2026) - GuruFocus
Prasanth Reddy Net Worth (2026) - GuruFocus
Jiming Zhou Net Worth (2026) - GuruFocus
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies - Sahm
20/20 Biolabs, Inc. Revenue Breakdown – NASDAQ:AIDX - TradingView
Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Biogen (BIIB) - The Globe and Mail
20/20 BioLabs provides update on protein biomarket technology for MCED - TipRanks
Jonathan Cohen Discloses Investment at 20/20 Biolabs with 16.8% Stake - TradingView
20/20 Biolabs (AIDX) CEO awarded 352,936-share stock option grant - Stock Titan
20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
20/20 Biolabs (AIDX) 10K Form and SEC Filings 2026 - MarketBeat
20/20 Biolabs Inc. (AIDX) Free Cash Flow (TTM) - Zacks Investment Research
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
20/20 Biolabs Inc. (AIDX) Price To Cash Flow - Zacks Investment Research
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
20/20 Biolabs Inc. (AIDX) Net Income (Quarterly) - Zacks Investment Research
AIDX News Today | Why did 20/20 Biolabs stock go down today? - MarketBeat
20/20 Biolabs (AIDX) Stock Price, News & Analysis - MarketBeat
20/20 Biolabs Inc. (AIDX) Cash From Operations (TTM) - Zacks Investment Research
Number of employees of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
20/20 Biolabs Inc. (AIDX) Cash From Financing (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Dividend Yield (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Shareholders Equity (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Profit Margin (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Revenue (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Assets (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Ps Ratio (TTM) - Zacks Investment Research
20/20 Biolabs, Inc. Common Stock (AIDX) Competitors - Meyka
20/20 Biolabs, Inc. Common Stock (AIDX) AI-Powered Stock Analysis - Meyka
AIDX News Today: Stay Updated with the Latest 20/20 Biolabs, Inc. Common Stock News in Real Time - Meyka
Why Is 20/20 Biolabs, Inc. Common Stock (AIDX) Stock Up Today? - Meyka
20/20 Biolabs, Inc. Common Stock (AIDX) Fundamental Analysis - Meyka
What is the current Price Target and Forecast for 20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
Operating income of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Non-operating income (total) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Diluted earnings per share (diluted EPS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Net income before discontinued operations of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
AIDX Price History for 20/20 Biolabs Stock - Barchart.com
Non-controlling/minority interest of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Equity in earnings of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
Taxes of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView
20 20 Biolabs Inc (AIDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):